A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis

Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazin...

Full description

Saved in:
Bibliographic Details
Published inProceedings - Baylor University. Medical Center Vol. 32; no. 2; pp. 231 - 234
Main Authors Espinosa, Maria Catalina, Ding, Belicia, Choi, Kati, Cohen, Daniel N, Marcelli, Marco, Ifoeze, Onome Whiteru
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis Ltd 03.04.2019
Taylor & Francis
Subjects
Case Studies
Drug use
Hypertension
Lupus
Medical diagnosis
Sarcoidosis
leukocytoclastic vasculitis
Drug-induced anti-neutrophil cytoplasmic antibody vasculitis
hydralazine
drug-induced lupus
Online AccessGet full text

Cover

More Information
Summary:Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.
Bibliography:Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/ubmc.
ISSN:0899-8280
1525-3252
DOI:10.1080/08998280.2019.1570422